Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model

Obesity Surgery

Volumn 26, Issue 8, 2016, Pages 1890-1899

  Zhang, Xiang ^a   Wang, Yanmin ^a   Zhong, Mingwei ^a   Liu, Teng ^a   Han, Haifeng ^a   Zhang, Guangyong ^a   Liu, Shaozhuang ^a   Wei, Meng ^a   Wu, Qunzheng ^a   Hu, Sanyuan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bile acids; Duodenal jejunal bypass; Glucagon like peptide 1; Gut microbiota; Type 2 diabetes mellitus

Indexed keywords

BILE ACID CONJUGATE; BILE ACID TRANSPORTER; CARRIER PROTEIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; MESSENGER RNA; TAURINE; UNCLASSIFIED DRUG; BILE ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDETES; BARIATRIC SURGERY; BILE ACID BLOOD LEVEL; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIABETES MELLITUS; DUODENAL JEJUNAL BYPASS; ENTEROHEPATIC CIRCULATION; FECES MICROFLORA; FIRMICUTES; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HORMONE RELEASE; ILEUM; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTESTINE FLORA; LIPID DIET; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOBACTERIA; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TERMINAL ILEUM; UPREGULATION; ANIMAL; BLOOD; DISEASE MODEL; DUODENUM; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; JEJUNUM; METABOLISM; MICROBIOLOGY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; WISTAR RAT;

ANIMALS; BILE ACIDS AND SALTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DUODENUM; GASTRIC BYPASS; GASTROINTESTINAL MICROBIOME; GLUCAGON-LIKE PEPTIDE 1; JEJUNUM; MALE; OBESITY, MORBID; RATS; RATS, WISTAR; TAURINE;

EID: 84951962723     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-2031-x     Document Type: Article

References (46)

1. Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.
2. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.
3. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10(3):167–77.
4. Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484–9.
5. Watanabe M, Houten SM, Wang L, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004;113(10):1408–18.
6. Ma K, Saha PK, Chan L, et al. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest. 2006;116(4):1102–9.
7. Cummings BP, Bettaieb A, Graham JL, et al. Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats. Dis Model Mech. 2013;6(2):443–56.
8. Han H, Wang L, Du H, et al. Expedited biliopancreatic juice flow to the distal gut benefits the diabetes control after duodenal-jejunal bypass. Obes Surg. 2015;25(10):1802–9.
9. Ferrannini E, Camastra S, Astiarraga B, et al. Increased bile acid synthesis and deconjugation after biliopancreatic diversion. Diabetes. 2015;64(10):3377–85.
10. Kohli R, Bradley D, Setchell KD, et al. Weight loss induced by roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab. 2013;98(4):E708–12.
11. de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17(5):657–69.
12. Islam KB, Fukiya S, Hagio M, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011;141(5):1773–81.
13. Swann JR, Want EJ, Geier FM, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4523–30.
14. Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5(178):178ra41.
15. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
16. Salonen A, Nikkila J, Jalanka-Tuovinen J, et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods. 2010;81(2):127–34.
17. Hu C, Zhang G, Sun D, et al. Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model. Obes Surg. 2013;23(9):1436–44.
18. Shonsey EM, Wheeler J, Johnson M, et al. Synthesis of bile acid coenzyme a thioesters in the amino acid conjugation of bile acids. Methods Enzymol. 2005;400:360–73.
19. Sjovall J. Dietary glycine and taurine on bile acid conjugation in man; bile acids and steroids 75. Proc Soc Exp Biol Med Soc Exp Biol Med. 1959;100(4):676–8.
20. Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metab Clin Exp. 2009;58(10):1400–7.
21. Kohli R, Kirby M, Setchell KD, et al. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol. 2010;299(3):G652–60.
22. Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009;19(11):1515–21.
23. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1–11.
24. Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity. 2012;20(6):1266–72.
25. Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res. 2007;24(10):1803–23.
26. Sayin SI, Wahlstrom A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17(2):225–35.
27. Craddock AL, Love MW, Daniel RW, et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998;274(1 Pt 1):G157–69.
28. Wu T, Bound MJ, Standfield SD, et al. Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. Diabetes, Obes Metab. 2013;15(5):474–7.
29. Murakami S. The role of taurine in the pathogenesis of obesity. Mol Nutr Food Res. 2015;19.
30. Rosa FT, Freitas EC, Deminice R, et al. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr. 2014;53(3):823–30.
31. Merheb M, Daher RT, Nasrallah M, et al. Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study. Diabetes Care. 2007;30(10):2652–4.
32. Tsuboyama-Kasaoka N, Shozawa C, Sano K, et al. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology. 2006;147(7):3276–84.
33. Kohli R, Setchell KD, Kirby M, et al. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology. 2013;154(7):2341–51.
34. Kaur A, Patankar JV, de Haan W, et al. Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1. Diabetes. 2014;22.
35. Haeusler RA, Astiarraga B, Camastra S, et al. Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids. Diabetes. 2013;62(12):4184–91.
36. Dutia R, Embrey M, O’Brien CS, Haeusler RA, Agenor KK, Homel P, et al. Temporal changes in bile acid levels and 12alpha-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes. 2015;39(5):806–13.
37. Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18(6):950–5.
38. Fang S, Suh JM, Reilly SM, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med. 2015;21(2):159–65.
39. Van Eldere J, Celis P, De Pauw G, et al. Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol. 1996;62(2):656–61.
40. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103.
41. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3.
42. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365–70.
43. Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049–57.
44. Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut. 2011;60(9):1214–23.
45. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488(7410):178–84.
46. Reddy BS. Diet and excretion of bile acids. Cancer Res. 1981;41(9 Pt 2):3766–8.